Morgan Stanley Portfolio holdings
Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ESRX
Express Scripts Holding Company
ESRX
|
+$2.7B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.39B |
| 3 |
AbbVie
ABBV
|
+$1.95B |
| 4 |
Wells Fargo
WFC
|
+$1.03B |
| 5 |
iShares Russell 2000 ETF
IWM
|
+$1.03B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Trip.com Group
TCOM
|
+$546M |
| 2 |
KRFT
KRAFT FOODS GROUP INC COM STK (VA)
KRFT
|
+$274M |
| 3 |
State Street SPDR S&P Regional Banking ETF
KRE
|
+$273M |
| 4 |
Home Depot
HD
|
+$257M |
| 5 |
Progressive
PGR
|
+$246M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 30.23% |
| 2 | Healthcare | 10.87% |
| 3 | Financials | 9.03% |
| 4 | Technology | 8.57% |
| 5 | Consumer Discretionary | 7.24% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
5151
RCI Hospitality Holdings
RICK
$196M
| $194K | ﹤0.01% |
16,298
-7,301
| -31% | -$85.2K |
2013 Q3
7 quarters
|
|
5152
Theriva Biologics
TOVX
$9.5M
| $194K | ﹤0.01% |
8
| – | – |
2013 Q2
8 quarters
|
|
5153
Aspen Aerogels
ASPN
$431M
| $193K | ﹤0.01% |
29,155
+26,905
| +1,196% | +$184K |
2014 Q2
4 quarters
|
|
5154
TPG Mortgage Investment Trust
MITT
$170M
| $193K | ﹤0.01% |
3,718
+291
| +8% | +$16.4K |
2013 Q2
8 quarters
|
|
5155
ProShares UltraShort Silver
ZSL
$76.3M
| $193K | ﹤0.01% |
22
+2
| +10% | +$16.3K |
2013 Q3
7 quarters
|
|
|
MTS
5156
DELISTED
MONTGOMERY STR INCOME SECS
MTS
| $193K | ﹤0.01% |
11,750
-29
| -0.2% | -$481 |
2013 Q2
8 quarters
|
|
|
VSR
5157
DELISTED
Versar, Inc.
VSR
| $193K | ﹤0.01% |
48,900
-27,500
| -36% | -$102K |
2014 Q4
2 quarters
|
|
|
GNAT
5158
DELISTED
WISDOMTREE TR GLOBAL NATURAL RESOURCES FND (DE)
GNAT
| $193K | ﹤0.01% |
12,418
+3,775
| +44% | +$63.1K |
2013 Q2
8 quarters
|
|
5159
DELISTED
THE CONTAINER STORE GROUP, INC.
TCS
| $192K | ﹤0.01% |
760
-1,499
| -66% | -$417K |
2013 Q4
6 quarters
|
|
5160
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
| $192K | ﹤0.01% |
4,143
-4,179
| -50% | -$156K |
2015 Q1
1 quarter
|
|
|
ROSG
5161
DELISTED
Rosetta Genomics Ltd.
ROSG
| $192K | ﹤0.01% |
4,706
-354
| -7% | -$15.1K |
2013 Q4
6 quarters
|
|
|
LBMH
5162
DELISTED
LIBERATOR MED HLDGS INC (NY)
LBMH
| $192K | ﹤0.01% |
84,608
+82,608
| +4,130% | +$239K |
2013 Q4
6 quarters
|
|
|
FRTX
5163
DELISTED
Fresh Tracks Therapeutics, Inc. Common Stock
FRTX
| $191K | ﹤0.01% |
86
+84
| +4,200% | +$263K |
2013 Q2
8 quarters
|
|
|
LOV
5164
DELISTED
Spark Networks SE American Depositary Shares
LOV
| $191K | ﹤0.01% |
62,271
+58,372
| +1,497% | +$204K |
2013 Q4
6 quarters
|
|
5165
Digital Turbine
APPS
$1.16B
| $190K | ﹤0.01% |
63,011
+9,211
| +17% | +$34.2K |
2014 Q1
5 quarters
|
|
5166
Inseego
INSG
$72.4M
| $187K | ﹤0.01% |
5,733
+1,236
| +27% | +$59.8K |
2013 Q2
8 quarters
|
|
5167
DELISTED
Global X MSCI Next Emerging & Frontier ETF
EMFM
| $187K | ﹤0.01% |
8,475
-6,984
| -45% | -$160K |
2014 Q3
3 quarters
|
|
|
IPCI
5168
DELISTED
Intellipharmaceuticals International Inc.
IPCI
| $187K | ﹤0.01% |
6,374
+260
| +4% | +$7.86K |
2013 Q4
6 quarters
|
|
|
SFE
5169
DELISTED
Safeguard Scientifics, Inc.
SFE
| $186K | ﹤0.01% |
9,536
+2,892
| +44% | +$53.1K |
2013 Q2
8 quarters
|
|
|
NXEO
5170
DELISTED
Nexeo Solutions, Inc. Common Stock
NXEO
| $186K | ﹤0.01% |
17,902
+16,397
| +1,090% | +$172K |
2014 Q3
3 quarters
|
|
|
PGN
5171
DELISTED
PARAGON OFFSHORE PLC (GBR)
PGN
| $186K | ﹤0.01% |
170,286
-51,742
| -23% | -$84K |
2014 Q3
3 quarters
|
|
5172
DELISTED
First Trust Brazil AlphaDEX Fund
FBZ
| $185K | ﹤0.01% |
13,620
-5,161
| -27% | -$73.2K |
2013 Q2
8 quarters
|
|
5173
Capricor Therapeutics
CAPR
$390M
| $184K | ﹤0.01% |
3,640
+752
| +26% | +$47.2K |
2015 Q1
1 quarter
|
|
5174
Magnachip Semiconductor
MX
$191M
| $184K | ﹤0.01% |
23,867
-3,343
| -12% | -$21.5K |
2013 Q2
8 quarters
|
|
|
MTBL
5175
DELISTED
Moatable, Inc. American Depositary Share (each representing forty-five (45) Class A Ordinary Shares)
MTBL
| $184K | ﹤0.01% |
32,317
+9,308
| +40% | +$46.7K |
2013 Q2
8 quarters
|
|
Similar funds
Morgan Stanley's Q2 2015 Portfolio in Review
As of Q2 2015, Morgan Stanley held 7,065 positions worth $289B, up 6.3% from $272B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Morgan Stanley deployed $19B of net new capital in Q2 2015, opening 213 new positions and adding to 3,439 existing holdings. Its largest new stake was EQGP Holdings, LP: 2,862,984 shares worth $97.3M.
By sector, the portfolio is most concentrated in Miscellaneous at 30% of assets, up from 30% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Trip.com Group, an estimated $546M trimmed.
- Morgan Stanley's largest Q2 2015 buy was EQGP Holdings, LP: 2,862,984 shares worth $97.3M.
- Morgan Stanley added most to Express Scripts Holding Company in Q2 2015, an estimated $2.7B increase.
- Morgan Stanley's biggest Q2 2015 reduction was Trip.com Group, cutting an estimated $546M.
- Morgan Stanley fully exited LORILLARD INC COM STK in Q2 2015, selling an estimated $162M.
- Morgan Stanley's ten largest holdings make up 12% of its $289B portfolio in Q2 2015.
- Morgan Stanley opened 213 new positions and closed 120 in Q2 2015.
- Morgan Stanley's portfolio value rose 6.3% quarter-over-quarter to $289B.
Based on Morgan Stanley's 13F filing for Q2 2015, filed 12 Aug 2015.